Physician profile
Simone K Guest
NPI 1558598177
$10,374.46
in general payments reported to CMS, 2019-2025
52 companies · $1,236 in 2025
The $1,236 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,837 · 2020: $1,591 · 2021: $1,059 · 2022: $1,350 · 2023: $1,613 · 2024: $1,689 · 2025: $1,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,537.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,557.19 | 2019-2025 | |
| Novo Nordisk INC | $1,291.05 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $794.38 | 2019-2025 | |
| Amgen INC. | $666.83 | 2019-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $562.54 | 2019-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $528.38 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $411.59 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $399.93 | 2019-2024 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $360.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $234.39 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $219.69 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $202.91 | 2023-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.70 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.20 | 2021-2025 | Xifaxan, Trulance |
| Allergan, INC. | $176.91 | 2019-2020 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simone Guest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.